Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Total Non-Current Liabilities of $48.4 billion for Q1 2026, down 6.02% year-over-year from $51.5 billion in Q1 2025, and down 7.02% quarter-over-quarter from $52.0 billion in Q4 2025.
Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Total Non-Current Liabilities for 18 consecutive years, with $48.4 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 6.02% year-over-year to $48.4 billion; the TTM figure through Mar 2026 stood at $48.4 billion (down 6.02% YoY), while the FY2025 annual figure was $52.7 billion, down 1.93% from the prior year.
- Total Non-Current Liabilities declined to $48.4 billion in Q1 2026 per BDX's latest filing, from $52.0 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $53.7 billion in Q3 2024 and bottomed at $47.9 billion in Q4 2023.
- Historically, Total Non-Current Liabilities has averaged $50.1 billion across 5 years, with a median of $49.9 billion in 2024.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities advanced 11.47% — and 2026, when it fell 6.02%.
- Becton Dickinson's Total Non-Current Liabilities stood at $48.3 billion in 2022, then declined by 0.84% to $47.9 billion in 2023, then climbed by 7.08% to $51.2 billion in 2024, then rose by 1.52% to $52.0 billion in 2025, then declined by 7.02% to $48.4 billion in 2026.
- Business Quant data shows BDX's Total Non-Current Liabilities at $48.4 billion in Q1 2026, $52.0 billion in Q4 2025, and $52.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 2.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.34 Bn |
| Mar 31, 2026 | 48.37 Bn |
| Dec 31, 2025 | 52.03 Bn |
| Sep 30, 2025 | 52.69 Bn |
| Jun 30, 2025 | 52.07 Bn |
| Mar 31, 2025 | 51.47 Bn |
| Dec 31, 2024 | 51.25 Bn |
| Sep 30, 2024 | 53.73 Bn |
| Jun 30, 2024 | 51.51 Bn |
| Mar 31, 2024 | 49.86 Bn |
| Dec 31, 2023 | 47.86 Bn |
| Sep 30, 2023 | 48.20 Bn |
| Jun 30, 2023 | 48.64 Bn |
| Mar 31, 2023 | 49.92 Bn |
| Dec 31, 2022 | 48.27 Bn |
| Sep 30, 2022 | 47.88 Bn |
| Jun 30, 2022 | 48.27 Bn |
| Mar 31, 2022 | 49.81 Bn |
| Dec 31, 2021 | 48.33 Bn |
| Sep 30, 2021 | 48.66 Bn |